[Hyderabad, May 14th, 2025] – The global poultry eubiotics market is projected to nearly double to $3.4 billion by 2031, according to ClearView Market Insights’s definitive 200-page report, revealing:
Request Sample @ https://clearviewmarketinsights.com/report-details/poultry-eubiotics-market/
Industry Transformation
- The $6B Necrotic Enteritis Solution
- DSM's patented phage-probiotic combo reduces lesions by 91%
- 89% of US integrators now include eubiotics in starter feeds
- Regulatory Tipping Point
- China's GB 7300-2023 standard forces 28% of producers to reformulate
- EU's 2024 zootechnical additive reclassification
- Technology Leapfrogging
- CRISPR-edited Bacillus survives pelleting at 85°C
- Cargill's AI platform cuts R&D time by 47%
Producer Economics
- Cost-Benefit Breakdown
Intervention | Cost/Ton | ROI (per 10,000 birds) |
Probiotics | $14.50 | $3,200 saved |
Organic Acids | $9.80 | $1,850 saved |
Phytogenics | $22.30 | $4,100 saved |
Regional Adoption
Market | 2024 Value | Growth Driver |
Asia | $720M | Thai CP Group mandate |
Europe | $540M | Antibiotic-free labeling |
Americas | $480M | Tyson's 2025 pledge |
Future Outlook
- 2025: First USDA-certified organic eubiotics
- 2026: 3D-printed gut microbiome modulators
- 2028: 40% of global production uses precision eubiotics
For more insights, visit https://clearviewmarketinsights.com/
About Clearview Market Insights:
Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
